Cologne 2017 Symposium: Innovative concepts in anti-inflammatory and anti(lymph)angiogenic therapies in the eye C. Cursiefen, K. Alitalo, T. Krieg, T. Langmann:Augenklinik, DFG Research Unit FOR 2240 Dept. of Ophthalmology Symposium,Innovative concepts in anti-inflammatory and anti(lymph)angiogenic therapies in the eye U. Gehlsen, D. Hos, C. Cursiefen, J. Horstmann, M. Coroneo, J. ... Read More
On the 20th and 21st of October 2017, the FOR 2240 symposium “Innovative concepts in anti-inflammatory and anti(lymph)angiogenic therapies in the eye” took place on the campus of the University of Cologne in the rooms of the Center for Molecular Medicine Cologne (http://www.cmmc-uni-koeln.de/home).The meeting was co-sponsored by the European Union (EU COST BM1302 “Joining Forces ... Read More
Over thirty members of the German Research Foundation (DFG) Research Unit FOR 2240 met on the 30th of June and the 1st of July 2017 in the Salvatorian Monastery of Steinfeld (Kloster Steinfeld). Already for the second time the principle investigators of the FOR 2240 and associated scientists and clinicians met in this quiet and ... Read More
On April 6th, 2017 Przemyslaw (“Mike”) Sapieha, PhD came to the Dept. of Ophthalmology of the University of Cologne as a Visiting Scientist in the German Research Foundation Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”. Dr. Sapieha is Director of the Neurovascular Eye Disease Lab and holds ... Read More
On June 21st, 2017, Dr. Ilva Rupenthal of the Department of Ophthalmology, University of Auckland, was a visiting scientist in the German Research Foundation (DFG) Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”. Dr. Rupenthal’s current research, co-funded by a Sir Charles Hercus ... Read More
On April 18th, 2017, Christiane Ruhrberg of the University College London Institute of Ophthalmology came to Cologne as Visiting Professor to the German Research Foundation Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”. Prof. Ruhrberg is Professor of Neuronal and Vascular Biology at UCL and holds a Wellcome ... Read More
In the framework of her visit to Cologne as Visiting Professor in the German Research Foundation Research Unit FOR 2240, Prof. Christiane Ruhrberg of the University College London Institute of Ophthalmology in the United Kingdom spent ample time with PD Dr. med. Franziska Bucher, FEBO (pictured center from left) and other Cologne scientists of the ... Read More
In May 2017, the journal Klinische Monatsblätter Augenheilkunde (engl. Clinical Monthly for Ophthalmology, founded in 1863) devoted a special issue to the Research Unit FOR 2240, whose main seat is in the Department of Ophthalmology at the University of Cologne. The Research Unit FOR 2240 “Angiogenesis, lymphangiogenesis and cellular immunity in inflammatory diseases of the ... Read More
Set to begin in July/August of 2017, PD Dr. med. Mario Matthaei, FEBO has landed a grant from the German Research Foundation (DFG) for a project that will investigate a micro-RNA target to treat Fuchs endothelial dystrophy. The project is called “Molecular investigations of miR-29-associated deposits of extra-cellular matrix in the course of Fuchs endothelial ... Read More
Dr. SriniVas Sadda came to Cologne to visit the Cologne Image Reading Center (CIRCL) on January 27th, 2017. Dr. Sadda is President & Chief Scientific Officer of the Doheny Eye Institute in Los Angeles, CA, USA and an internationally highly renowned expert in the diagnosis and treatment of (chorio-) retinal diseases, with a particular strength ... Read More
